Sample preparation: a challenge in the development of point-of-care nucleic acidbased assays for resource-limited settings

被引:136
作者
Dineva, Magda Anastassova [1 ]
Mahilum-Tapay, Lourdes [1 ]
Lee, Helen [1 ]
机构
[1] Univ Cambridge, Dept Haematol, Cambridge CB2 2PT, England
基金
英国惠康基金;
关键词
D O I
10.1039/b705672a
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学]; 081704 [应用化学];
摘要
Currently available nucleic acid testing ( NAT)-based assays are complex and time-consuming, and they require expensive instrumentation and dedicated laboratory spaces for sample preparation as well as for amplification and detection of the nucleic acid target. Reagents required for these tests are also expensive and must be transported and stored refrigerated or frozen. These characteristics have limited the use of such assays for point-of-care ( POC) testing, especially in resource-poor settings. Efforts to develop simple and rapid NAT-based assays have focused predominantly on the amplification and detection steps, with sample preparation and nucleic acid extraction remaining the bottleneck in the development of NAT systems suitable for POC applications or resource-limited settings. A review of NAT platforms and technologies currently under development and validation for rapid field testing revealed that, in addition to requiring expensive and complex instrumentation, many of these systems also require off-line sample preparation and reagent handling. In their current format, they are therefore not appropriate for POC testing in resource-limited settings. We evaluated several commercially available technologies and procedures for the isolation of nucleic acid with the extraction of HIV-1 RNA from human plasma as a model system. Our results indicate that solid-phase extraction with silica or glass in the presence of a chaotropic salt provides the highest extraction efficiency. However, none of the existing methods and technologies is readily adaptable to a POC system. The integration of sample preparation procedures well suited to NAT-based assays in resource-limited settings therefore remains a challenge.
引用
收藏
页码:1193 / 1199
页数:7
相关论文
共 38 条
[1]
AKER MJ, 2000, Patent No. 1036082
[2]
Occult hepatitis B virus infection: implications in transfusion [J].
Allain, JP .
VOX SANGUINIS, 2004, 86 (02) :83-91
[3]
[Anonymous], 2006, REP GLOB AIDS EP
[4]
Fast DNA serotyping of Escherichia coli by use of an oligonucleotide microarray [J].
Ballmer, Karin ;
Korczak, Lozena M. ;
Kuhnert, Peter ;
Slickers, Peter ;
Ehricht, Ralf ;
Haechler, Herbert .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) :370-379
[5]
RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[6]
Burgoyne L. A., 2001, US Patent, Patent No. [6322983B, 6322983]
[7]
Burgoyne LA., 1996, US patent, Patent No. 5496562
[8]
BURGOYNE LA, 2001, Patent No. 6294203
[9]
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 [J].
Candotti, D ;
Temple, J ;
Owusu-Ofori, S ;
Allain, JP .
JOURNAL OF VIROLOGICAL METHODS, 2004, 118 (01) :39-47
[10]
CHEN CHEN, 2004, Patent No. 6780617